Focus Financial Network, Inc. Halozyme Therapeutics, Inc. Transaction History
Focus Financial Network, Inc.
- $2.8 Trillion
- Q3 2025
A detailed history of Focus Financial Network, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Focus Financial Network, Inc. holds 3,787 shares of HALO stock, worth $258,424. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,787Holding current value
$258,424% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
641Shares Held
126MCall Options Held
408KPut Options Held
384K-
Black Rock Inc. New York, NY17.6MShares$1.2 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$794 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$405 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$237 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$232 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.51B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...